The Experience of Using “Neovasculgen” in the Complex Treatment of Patients with Critical Lower Limb Ischemia

The Experience of Using “Neovasculgen” in the Complex Treatment of Patients with Critical Lower Limb Ischemia

This article presents an assessment of the clinical efficacy and long-term results of the use of pl-VEGF165 (a gene therapy drug Neovasculgen) in the treatment of patients with critical lower limb ischemia. The present study revealed a significant decrease in the degree of ischemia, pain reduction a...

Full description

Bibliographic Details
Main Authors: Mikhail M. Vinokurov, Anton A. Yakovlev, Innokenty D. Ushnitsky, Gennady A. Palshin, Aleksander P. Petrov, Vladimir V. Popov, Tatyana V. Yalinskaya
Format: Article
Language:English
Published: International Medical Research and Development Corporation 2020-09-01
Series:International Journal of Biomedicine
Subjects:
chronic lower limb ischemia
lower extremity arteries
pain-free walking distance
linear blood flow velocity
Online Access:http://ijbm.org/articles/i39/ijbm_10(3)_shc1.pdf

Internet

http://ijbm.org/articles/i39/ijbm_10(3)_shc1.pdf

Similar Items